Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Adicionar filtros








Intervalo de ano
1.
Journal of Third Military Medical University ; (24)2003.
Artigo em Chinês | WPRIM | ID: wpr-678320

RESUMO

Objective To study the mechanism of carvedilol therapy of congestive heart failure. Methods After chronic heart failure model was established by ligation of the left coronary artery in rats, rats were treated with carvedilol and terazosin. Then hemodynamic parameters, activity of sarcoplasmic reticulum(SR) Ca 2+ pump(SERCA 2a ) and the rate of cardiomyocyte apoptosis were determined. Results Compared with those of the control group( group C), the activity of SR Ca 2+ pump in the heart failure group(group F) decreased( P 0.05). Carvedilol intervention reduced the rate of cardiomyocyte apoptosis, but enhanced the activity of SR Ca 2+ pump significantly in dose dependent manner. The activity of SR Ca 2+ pump was negatively correlated with the rate of cardiomyocyte apoptosis( r =-0.814, P

2.
Chinese Journal of Urology ; (12)2001.
Artigo em Chinês | WPRIM | ID: wpr-536985

RESUMO

Objective To analysis the impact of ? blocker therapy on symptoms of benign prostatic hyperplasia(BPH). Methods 148 cases of BPH patients had been treated with ? blocker for 4 weeks. Symptom score, uroflowmetry and post voiding residual urine were recorded and analyzed. Results After 4 weeks of treatment, the IPSS, uroflowmetry and residual volume were improved significantly, P 0.1. Conclusions Reduction of symptoms and improvements of uroflowmetry in BPH patients treated with ? blocker.might be initiated through different mechanisms.

3.
Clinical Medicine of China ; (12)2000.
Artigo em Chinês | WPRIM | ID: wpr-536264

RESUMO

Objective To study the effects of ? blocker on heart rate variability (HRV) of dilated cardiomyopathy and ? receptor sentivity and cardiac function.Methods HRV was analyzed by use of Holter monitoring and isopnenaline sensitivity test was performed in patients with dilated cardiomyopathy.CD 25 was measured.Cardiac function was measured by use of ultrasonography.Results SDNN,LF,HF and HRVI in the treatment group were increased compared with those before treatment(P

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA